Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
Ball
R
R
Brownlee
K G
KG
Duff
A J A
AJ
Denton
M
M
Conway
S P
SP
Lee
T W R
TW
D000293:Adolescent; D000584:Amiloride / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D019121:Burkholderia Infections / Q000150:complications* / Q000188:drug therapy*; D042602:Burkholderia cepacia complex / Q000187:drug effects*; D002648:Child; D003550:Cystic Fibrosis / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D009330:Nebulizers and Vaporizers; D026941:Sodium Channel Blockers / Q000008:administration & dosage; D014031:Tobramycin / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D026941:Sodium Channel Blockers; D000584:Amiloride; D014031:Tobramycin